CAL
AVXL icon

Capital Advisors Ltd’s Anavex Life Sciences AVXL Stock Holding History

Capital Advisors Ltd’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+484
New +$1.43K ﹤0.01% 1174

Other funds holding AVXL

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
LA
LexAurum Advisors Overland Park, Kansas $866M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return

Capital Advisors Ltd's AVXL Position: Q2 2026 in Review

Capital Advisors Ltd opened a new position in Anavex Life Sciences (AVXL) in Q2 2026: 484 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1174 among its holdings.

13 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Capital Advisors Ltd held 484 shares of Anavex Life Sciences worth $1K as of Q2 2026.
  • Anavex Life Sciences was a new Capital Advisors Ltd position in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1174 holding.
  • 13 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.